Subscribe to NRx Newsletter

NRx Business Update

NRx Pharmaceuticals to Report Third Quarter 2021 Financial and Business Update on Tuesday, November 16, 2021

–Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET– RADNOR, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) — NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical-stage, global biopharmaceutical company, today announced that management will report third-quarter 2021 financial results before the market opens on Tuesday, November 16, 2021. The Company will host a […]